Pricing Log in Create free account
Tuesday 3 November 2026 Export MOH’s income statement to Excel — free account

Molina Healthcare, Inc

MOH Healthcare Healthcare Plans

Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024.

Revenue
−3.44%
EPS
−51.7%
Free cash flow
−20.3%
Total debt
+2.54%

Quarter to September 2026, against a year earlier

208.21 3.43 +1.67%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
59.6×
Dividend yield
—
F-score
4/9
Altman Z
4.28
Beneish M
−1.99
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Filings

Molina Healthcare, Inc (MOH) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Oct 21, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026
8-K Jul 22, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 10, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 6, 2026 5.02 Departure or appointment of directors or officers; 5.03 Amendments to the articles or bylaws; change in fiscal year; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits Officer departure
8-K May 8, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 22, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 26, 2026 7.01 Regulation FD disclosure
10-K Dec 31, 2025 1: 42 added · 45 removed · 74 modified
1A: 17 added · 14 removed · 65 modified
7: 27 added · 28 removed · 54 modified
8-K Feb 4, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 2.06 Material impairment; 9.01 Financial statements and exhibits Impairment
8-K Feb 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 20, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Nov 17, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Nov 17, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Nov 14, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 22, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Jul 23, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 7, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K Apr 23, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 5, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Oct 23, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Jul 24, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 24, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.